India's Jubilant Pharmova reported a 51% jump in third-quarter profit on Friday, driven by a strong demand for its drugs with ...
The FMCG major was expected to report a fall in Oct-Dec net profit due to weak operational performance and margin squeeze ...
In the December quarter, 3 out of 4 product groups delivered healthy growth led by a combination of pricing and volume. Key ...
HYDERABAD/BENGALURU (Reuters) -Sun Pharmaceutical, India's largest drugmaker by revenue, reported a bigger-than-expected ...
Nestlé India reported a 5% increase in net profit for Q3FY25, reaching ₹688 crore. Revenue rose by 4% to ₹4,779 crore. EBITDA ...
Nestlé India Q3 net profit rises 6% YoY to Rs 696 crore, meets estimates; cost pressures persist on coffee and cocoa.
ICICI Securities said Kalyan continued to outperform Titan in Q3FY25 with strong standalone jewellery revenue growth of 41 ...
Nestlé India posted Q3 revenue from operations at Rs 4779.73 crore, up 3.90 per cent as against Rs 4600.42 crore during the ...